BFG
KYNB

Beacon Financial Group’s Kyntra Bio KYNB Stock Holding History

Beacon Financial Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-240
Closed -$257K – 174
2019
Q4 		$257K Hold
240
– – 0.03% 185
2019
Q3 		$227K Hold
240
– – 0.04% 184
2019
Q2 		$271K Hold
240
– – 0.05% 182
2019
Q1 		$326K Hold
240
– – 0.05% 158
2018
Q4 		$269K Buy
+240
New +$270K 0.05% 169

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Beacon Financial Group's KYNB Position: Q1 2020 in Review

Beacon Financial Group sold out of Kyntra Bio (KYNB) in Q1 2020, closing a stake of 240 shares — an estimated $257K sold.

Beacon Financial Group first reported a position in KYNB in Q4 2018 and held it in 5 quarters. The position peaked at $326K in Q1 2019. 187 funds tracked by Wall St. Rank hold KYNB as of Q1 2020.

  • Beacon Financial Group reported no remaining Kyntra Bio position as of Q1 2020 after selling out during the quarter.
  • Beacon Financial Group sold 240 Kyntra Bio shares in Q1 2020, an estimated $257K.
  • Beacon Financial Group first reported a position in Kyntra Bio in Q4 2018 and held it in 5 quarters.
  • Beacon Financial Group's Kyntra Bio position peaked at $326K in Q1 2019.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2020.

Based on Beacon Financial Group's 13F filing for Q1 2020, filed 29 Jun 2020.